Technology Industry

Industry: Email Alert RSS Feed
Comments

Venture capital watch

BT Catalyst, Nov-Dec, 2004

Two venture capital deals worth $32.5 million were announced in September and October by North Carolina biotechnology companies.

Cellective Therapeutics, Durham, $27.5 million Investors: Intersouth Partners of Durham; Alta Partners; BA Venture Partners; Forward Ventures; Genentech, Inc.; Latterell Venture Partners; MedImmune Ventures, Inc.; Sofinnova Ventures.

Most RecentTechnology Articles

Metabolon, Durham, $5 million Investors: Sevin Rosen Funds; The Aurora Funds; Trelys Ventures, Alexandria Real Estate Equities; individual investors.

COPYRIGHT 2004 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
CXO UnpluggedSmart Business interviews on BNET

See and hear how senior level executives across the Asia Pacific are developing smart business ideas across a variety of sectors. The focus is on the future, and on how businesses need to evolve.

Brought to you by CBS MoneyWatch.com

advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale